If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvancedadvt Regulatory News (ADVT)

Share Price Information for Advancedadvt (ADVT)

Share Price is delayed by 15 minutes
Get Live Data
155.00    0.00 (0.00%)
Bid:
150.00
Ask:
160.00
Spread: 10.00 (6.667%)
Market Cap: £204.83m
ADVT Live PriceLast checked at - London Stock Exchange

Intraday Advancedadvt Share Chart

Admission to AIM

10 Jan 2024 07:00

RNS Number : 1662Z
Advancedadvt Limited
10 January 2024
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM THE UNITED STATES OF AMERICA (THE "UNITED STATES" OR THE "US"), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

 

10 January 2024

 

AdvancedAdvT Limited

 

Admission to AIM

 

AdvancedAdvT Limited (AIM: ADVT, "AdvT", the "Company"), the international software solutions provider for the business solutions, healthcare compliance, and human capital management sectors, announces the admission of its Ordinary Shares to trading on AIM. Dealings will commence at 8.00 a.m. today, Wednesday 10 January 2024, under the ticker ADVT and ISIN VGG0103J1075.

 

The Company's Admission Document is available on its website at www.advancedadvt.com.

 

Enquiries:

 

AdvancedAdvT Limited

Vin Murria, Chairperson

Gavin Hugill, Chief Financial Officer

c/o Meare Consulting

Singer Capital Markets (Nominated Adviser and Broker)

Tel: 020 7496 3000

Philip Davies / Asha Chotai / Sam Butcher

KK Advisory (Investor Relations)

Tel: 020 7039 1901

Kam Bansil 

 

Meare Consulting 

Adrian Duffield

Tel: 07990 858548

 

Note to Editors

 

AdvancedAdvT Limited (AdvT) provides software solutions and platforms across two business transformational areas: business solutions & healthcare compliance, and human capital management.

 

The Group's operations are IBSS (financial management software), CHKS (AI based healthcare intelligence compliance and accreditation software), Retain (global resource planning and talent management software) and WFM (workforce management software provider).

 

AdvT is an agent for change. The Group enables the delivery of Artificial Intelligence ("AI"), data analytics and business intelligence, all of which are key future drivers for growth in these sectors where long term digitisation trends are set to transform the workplace for professionals. 

 

AdvT is developing both organically and through acquisitions, by expanding its presence across adjacent markets, geographical boundaries and digital sectors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDBGDBLSGDGSC
Date   Source Headline
29th Sep 20227:00 amRNSUpdate on Acceptance Levels
28th Sep 202210:21 amRNSForm 8.5 (EPT/RI)
28th Sep 20229:49 amGNWRule 8.3 - AdvancedAdvt Limited
28th Sep 20227:00 amRNSUpdate on Acceptance Levels
27th Sep 20224:19 pmRNSPublication of Supplemental Prospectus
27th Sep 20227:00 amRNSUpdate on Acceptance Levels
26th Sep 20222:19 pmRNSRule 8.3- ADVT
26th Sep 20221:51 pmRNSADV Acceptance Levels and Rejection of ADV Offer
26th Sep 202211:44 amRNSForm 8.5 (EPT/RI)
26th Sep 202210:36 amGNWRule 8.3 - AdvancedAdvT Limited
26th Sep 20227:00 amRNSUpdate on Acceptance Levels
23rd Sep 20227:00 amRNSUpdate on Acceptance Levels
23rd Sep 20227:00 amRNSUpdate on Acceptance Levels
22nd Sep 20227:00 amRNSUpdate on Acceptance Levels
21st Sep 20229:03 amRNSForm 8.5 (EPT/RI)
20th Sep 202210:37 amRNSForm 8.3 - ADVT
20th Sep 202210:20 amRNSForm 8.5 (EPT/RI)
16th Sep 20229:02 amRNSForm 8.5 (EPT/RI)
15th Sep 20221:11 pmRNSForm 8.3 - AdvancedAdvT Limited
15th Sep 202212:04 pmRNSForm 8.5 (EPT/RI)
15th Sep 202211:00 amRNSNet Asset Value(s)
15th Sep 20227:00 amRNSUpdate on Acceptance Levels
14th Sep 202210:40 amRNSForm 8.5 (EPT/RI)
13th Sep 20229:06 amRNSForm 8.5 (EPT/RI)
13th Sep 20227:00 amRNSContinued Rejection of ADV Offer
12th Sep 20229:21 amRNSForm 8.5 (EPT/RI)
9th Sep 202210:19 amRNSForm 8.5 (EPT/RI)
8th Sep 202210:28 amRNSResponse to ADV’s Acceleration Statement
8th Sep 20227:00 amRNSAcceleration Statement
2nd Sep 202212:00 pmRNSForm 8.5 (EPT/RI)
1st Sep 202210:11 amRNSForm 8.5 (EPT/RI)
31st Aug 202210:26 amRNSForm 8.5 (EPT/RI)
22nd Aug 20221:47 pmRNSForm 8.3 - M&C SAATCHI
22nd Aug 202211:07 amRNSForm 8.5 (EPT/RI)
19th Aug 202211:00 amRNSAdjournment of M&C Saatchi Meetings
16th Aug 20221:00 pmRNSForm 8.3 - M&C SAATCHI
16th Aug 20227:00 amRNSUpdate on Final Offer for M&C Saatchi
15th Aug 20224:45 pmRNSUpdate for Shareholders on Regulatory Filings
15th Aug 20223:06 pmRNSForm 8.3 - M&C SAATCHI
15th Aug 202211:59 amRNSUpdate on Final Offer for M&C Saatchi
12th Aug 20223:32 pmRNSForm 8.3 - M&C SAATCHI
10th Aug 20223:03 pmRNSForm 8.3 - M&C SAATCHI
10th Aug 202211:45 amRNSForm 8.5 (EPT/RI)
9th Aug 20222:20 pmRNSForm 8.3 - M&C SAATCHI
9th Aug 20229:00 amRNSForm 8.5 (EPT/RI)
4th Aug 20229:16 amRNSForm 8.5 (EPT/RI)
3rd Aug 202211:28 amRNSForm 8.5 (EPT/RI) - Advancedadvt Limited
2nd Aug 20222:34 pmRNSForm 8.3 - M&C SAATCHI
2nd Aug 20229:55 amRNSForm 8.5 (EPT/RI)
1st Aug 20229:45 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.